Share This Page
Drug Price Trends for NDC 33342-0051
✉ Email this page to a colleague
Average Pharmacy Cost for 33342-0051
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | 33342-0051-10 | 0.08662 | EACH | 2024-12-18 |
| LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | 33342-0051-44 | 0.08662 | EACH | 2024-12-18 |
| LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | 33342-0051-07 | 0.08662 | EACH | 2024-12-18 |
| LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | 33342-0051-44 | 0.07463 | EACH | 2024-11-20 |
| LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB | 33342-0051-10 | 0.07463 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 33342-0051
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
33342-0051 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 33342-0051
Understanding the National Drug Code (NDC)
To begin analyzing the market and pricing for a drug identified by the NDC 33342-0051, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, the product, and the trade package size of a drug product. This code is essential for tracking and managing drug products in the pharmaceutical industry[1][5].
Identifying the Drug Product
The NDC 33342-0051 can be broken down into three segments:
- Labeler Code: The first segment (33342) identifies the firm that manufactures, repackages, or relabels the drug.
- Product Code: The second segment (0051) identifies the specific strength, dosage form, and formulation of the drug.
- Package Code: The third segment identifies the package size and type[1][3].
Market Trends in the Pharmaceutical Industry
Digital Transformation and Innovation
The pharmaceutical industry is expected to see substantial growth and transformation driven by digital advancements and scientific innovations. This includes the integration of technologies like gen AI and increased use of data to boost operational efficiencies and drive breakthrough innovations. These advancements can lead to better production processes, potentially reducing costs and stabilizing or lowering prices[1].
Pricing and Access
Pricing and access to drugs remain significant issues. Nearly half of the C-suite executives surveyed expect these factors to significantly affect their strategies. This trend is particularly relevant when considering the pricing dynamics of specific drugs, as companies must balance profitability with patient access and affordability[1].
Generic Drugs and Biosimilars
Competition from generic drugs and biosimilars is a top trend, with a significant portion of respondents viewing it as a major concern. The patent cliff, with over $300 billion in sales at risk through 2030, is also a significant factor driving interest in mergers and acquisitions[1].
Market Demand Analysis
Patient Population and Disease Prevalence
To project prices and market trends, it is essential to understand the demand for the drug. This involves analyzing the patient population and the prevalence of the condition the drug treats. For example, if the drug treats a chronic condition with a growing patient population, demand is likely to increase, which could support higher pricing[3].
Competitive Landscape
The competitive landscape plays a significant role in determining the market position and pricing of the drug. If there are few competitors in the same therapeutic class, the drug may maintain a strong market position. However, if there is intense competition, especially from generic drugs or biosimilars, the pricing strategy may need to be adjusted to remain competitive[3].
Pricing Dynamics
Discounts and Programs
Programs like the 340B Drug Pricing Program play a crucial role in shaping the pricing landscape. This program requires drug companies to offer discounted prices on certain outpatient drugs to hospitals caring for large numbers of underserved patients. While these discounts are a small share of drug company revenues (approximately 3.1% of global revenues and 7% of U.S. revenues), they can impact the overall pricing strategy for drugs[1].
Market Pricing
The price of a drug like the one identified by NDC 33342-0051 would be influenced by various factors, including production costs, market demand, competition from generics or biosimilars, and regulatory policies. For instance, if the drug is nearing the end of its patent life, the price might decrease due to anticipated competition from generics[1].
Price Projections
Current Pricing
To project future prices, one must first understand the current pricing. This involves looking at recent pricing data, such as that provided in specialty MAC (Maximum Allowable Cost) lists or other pharmaceutical pricing databases. For example, the Missouri Specialty MAC list provides detailed pricing information for various drugs, although specific NDCs may not always be listed[1].
Future Trends
Given the trends in the pharmaceutical industry:
- Digital Transformation: Increased efficiency and innovation could lead to better production processes, potentially reducing costs and stabilizing or lowering prices.
- Pricing and Access: Continued pressure on pricing and access could result in more competitive pricing strategies.
- Generic and Biosimilar Competition: If the drug is nearing the end of its patent life, the introduction of generics or biosimilars could significantly reduce its price[1].
Key Factors Influencing Price
Regulatory Changes
Changes in regulatory policies, such as those affecting the 340B program or patent exclusivity, can significantly impact drug pricing. For instance, expansions of the 340B program could lead to more discounted prices for certain patient groups[1].
Market Demand
The demand for the drug, influenced by factors such as disease prevalence, treatment efficacy, and patient population, will also play a crucial role in determining its price. A growing patient population or increased treatment efficacy can support higher pricing, while a declining patient population or reduced efficacy could lead to lower prices[3].
Competition
The presence of competitors, whether branded, generic, or biosimilar, will drive pricing decisions. As more drugs lose patent protection, the market is likely to see increased competition, which generally leads to lower prices[1].
Forecasting Models
Regression Analysis
Using historical data, regression models can be built to predict future prices based on past trends and market conditions. This method helps in identifying the relationship between the drug's price and various market factors such as demand, competition, and economic conditions[3].
Time Series Analysis
Time series analysis involves identifying patterns and cycles in historical data to forecast future prices. This method can reveal seasonal patterns or other periodic changes in pricing that need to be considered in price projections[3].
External Factors
Economic Conditions
Economic conditions such as inflation rates and healthcare spending trends can significantly influence drug pricing. For example, if inflation is rising, drug prices may also increase to keep pace with the cost of living[3].
Policy Changes
Policy changes, such as changes in Medicare or Medicaid reimbursement rates, can impact the pricing of drugs. Staying updated with FDA regulations and other policy changes is essential for maintaining market position and compliance[3].
Scenario Analysis
Best-Case Scenario
In a best-case scenario, the drug faces high demand and limited competition, allowing for optimal pricing. This scenario assumes favorable market conditions and strong market positioning[3].
Worst-Case Scenario
In a worst-case scenario, the drug faces intense competition or regulatory challenges, leading to lower prices or reduced market share. This scenario helps in preparing for adverse market conditions[3].
Base-Case Scenario
The base-case scenario projects prices based on current market conditions and trends. This is often the most realistic scenario and serves as a benchmark for other projections[3].
Illustrative Statistics
- 340B Discounts: In 2022, drug companies provided an estimated $46.5 billion in discounts to 340B hospitals, which is roughly 3.1% of global revenues and 7% of U.S. revenues[1].
- Patent Cliff: Over $300 billion in sales are at risk through 2030 due to expiring patents on high-revenue products, which could lead to significant price adjustments as generics and biosimilars enter the market[1].
Expert Insights
Industry experts emphasize the importance of personalized medicine and the use of advanced technologies like genomics and biomarkers to provide more precise treatment options. This not only improves efficacy but also reduces side effects, which can influence patient demand and, consequently, pricing strategies.
"Personalized medicine and advanced technologies like genomics and biomarkers are crucial for improving treatment efficacy and reducing side effects, which in turn can influence patient demand and pricing strategies," - Industry Expert[1].
Key Takeaways
- Market Trends: Digital transformation, pricing and access pressures, and competition from generics and biosimilars are key drivers.
- Regulatory Impact: Programs like the 340B Drug Pricing Program and changes in patent exclusivity can significantly affect pricing.
- Demand and Competition: Market demand and the presence of competitors will influence the drug's price.
- Technological Advancements: Innovations in genomics, biomarkers, and AI can improve treatment efficacy and reduce costs[1].
FAQs
What is the National Drug Code (NDC) and how is it used?
The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, the product, and the trade package size of a drug product. It is used for tracking and managing drug products in the pharmaceutical industry[1][5].
How do programs like the 340B Drug Pricing Program affect drug pricing?
Programs like the 340B Drug Pricing Program require drug companies to offer discounted prices on certain outpatient drugs to hospitals caring for large numbers of underserved patients. These discounts can impact the overall pricing strategy for drugs, although they represent a small share of drug company revenues[1].
What role does competition from generics and biosimilars play in drug pricing?
Competition from generics and biosimilars can significantly reduce the price of a drug, especially if the drug is nearing the end of its patent life. This competition generally leads to lower prices as more affordable alternatives enter the market[1].
How do economic conditions influence drug pricing?
Economic conditions such as inflation rates and healthcare spending trends can influence drug pricing. Rising inflation, for example, may lead to increased drug prices to keep pace with the cost of living[3].
What is the impact of digital transformation on the pharmaceutical industry?
Digital transformation, including the integration of technologies like gen AI and increased use of data, can lead to better production processes, potentially reducing costs and stabilizing or lowering prices. It also drives breakthrough innovations and improves operational efficiencies[1].
Sources
- DrugPatentWatch - Market Analysis and Price Projections for the Drug NDC: 33342-0309[1].
- HHS.gov - Medicare Part B Drug Average Sales Price Reporting by Manufacturers[2].
- DrugPatentWatch - Market Analysis and Price Projections for the Drug NDC: 33342-0308[3].
- CDC - IIS | Code Sets | NDC | Vaccines[4].
- FDA - National Drug Code Directory[5].
More… ↓
